3 causes Bernstein strategists are bullish on the EU pharma sector into 2025

Investing.com — Bernstein analysts are optimistic in regards to the European pharmaceutical sector because it heads into 2025, regardless of issues over coverage adjustments and market headwinds. The agency outlined its three key causes for the constructive outlook in a observe…